Accuray (ARAY) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Lake Street Maintains Accuray(ARAY.US) With Buy Rating, Maintains Target Price $6
Moomoo NewsNov 7 09:35 ET · Ratings
Lake Street Keeps Their Buy Rating on Accuray (ARAY)
TipRanksNov 7 09:03 ET · Ratings
Accuray Incorporated Reports Strong Start to Fiscal 2025
TipRanksNov 6 23:10 ET
Accuray Incorporated (ARAY) Q1 2025 Earnings Call Transcript Summary
moomoo AINov 6 22:37 ET · Conference Call
Accuray (ARAY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Yahoo FinanceNov 6 18:00 ET
Accuray Inc. Optimistic Despite Revenue Decline
TipRanksNov 6 16:49 ET

Comments

Trytosaveabit

Oct 17 06:13

Update

$Accuray (ARAY.US)$ Accuray Announced That Results Of The Pace-B– Prostate Advances In Comparative Evidence – Trial Were Published In The New England Journal Of Medicine
Benzinga· 3 mins ago
The research builds on previously reported data and shows that at five years, stereotactic body radiation therapy (SBRT) provides comparable rates of cancer control, tolerability and sexual functioning to conventional radiotherapy (CRT), while reducing the overall treatment timeframe from up to 39 days ...

1

Trytosaveabit

Sep 10 16:39

News

$Accuray (ARAY.US)$ Gifu Prefectural General Medical Center Achieves Milestone with Treatment of the First Cancer Patients in Japan Using the Accuray Radixact® System and VitalHold™ Solution
8 MINUTES AGO, 5:30 PM EDT
VIA PR NEWSWIRE
The Technology Will Play an Important Role in the Hospital's Plan to Expand Patient Access to High Precision Radiation Therapy Treatments
MADISON, Wis., Sept. 10, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Gifu Prefectural Gene...

3

13

Jaguar8

Sep 10 16:34

NEWS

$Accuray (ARAY.US)$
Gifu Prefectural General Medical Center Achieves Milestone with Treatment of the First Cancer Patients in Japan Using the Accuray Radixact® System and VitalHold™ Solution

1

Jaguar8

Aug 27 06:36

NEWS

$Accuray (ARAY.US)$
Accuray Receives CE Mark for a New Helical Radiation Delivery System, Accuray Helix™
Accuray Incorporated (NASDAQ: ARAY) has received CE Mark for Accuray Helix™, a new CT-guided helical radiotherapy system designed for emerging markets with access to advanced cancer care. The system aims to provide high-performance, high-throughput radiotherapy in non-urban communities, offering short treatment times and cost-effectiveness.
Accuray Helix is part of the company's strategic...

1

ARAY Accuray

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target